The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells

Publication date: April 2018

Source: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1869, Issue 2

Author(s): Catherine J. Libby, Anh Nhat Tran, Sarah E. Scott, Corinne Griguer, Anita B. Hjelmeland

Abstract

De-regulated cellular energetics is an emerging hallmark of cancer with alterations to glycolysis, oxidative phosphorylation, the pentose phosphate pathway, lipid oxidation and synthesis and amino acid metabolism. Understanding and targeting of metabolic reprogramming in cancers may yield new treatment options, but metabolic heterogeneity and plasticity complicate this strategy. One highly heterogeneous cancer for which current treatments ultimately fail is the deadly brain tumor glioblastoma. Therapeutic resistance, within glioblastoma and other solid tumors, is thought to be linked to subsets of tumor initiating cells, also known as cancer stem cells. Recent profiling of glioblastoma and brain tumor initiating cells reveals changes in metabolism, as compiled here, that may be more broadly applicable. We will summarize the profound role for metabolism in tumor progression and therapeutic resistance and discuss current approaches to target glioma metabolism to improve standard of care.

https://ift.tt/2u8QnEe